LETTER TO THE EDITOR
Response to: Eculizumab use throughout pregnancy in two patients with aquaporin-4-positive neuromyelitis optica spectrum disorder
Ilya Kister,
Ilya Kister
NYU Multiple Sclerosis Center, NYU Grossman School of Medicine New York, New York, New York, USA
Search for more papers by this author Alla Wilson,
Corresponding Author
Alla Wilson
NYU Multiple Sclerosis Center, NYU Grossman School of Medicine New York, New York, New York, USA
Shields Health Solutions, Stoughton, USA
Correspondence
Alla Wilson, NYU Multiple Sclerosis Center, NYU Grossman School of Medicine, 12 Verly Court, Bethpage, NY 11714, USA.
Email: [email protected]
Search for more papers by this author
Ilya Kister,
Ilya Kister
NYU Multiple Sclerosis Center, NYU Grossman School of Medicine New York, New York, New York, USA
Search for more papers by this author Alla Wilson,
Corresponding Author
Alla Wilson
NYU Multiple Sclerosis Center, NYU Grossman School of Medicine New York, New York, New York, USA
Shields Health Solutions, Stoughton, USA
Correspondence
Alla Wilson, NYU Multiple Sclerosis Center, NYU Grossman School of Medicine, 12 Verly Court, Bethpage, NY 11714, USA.
Email: [email protected]
Search for more papers by this author
First published: 10 July 2024
No abstract is available for this article.
REFERENCES
- 1Fujimoto T, Maeda Y. Eculizumab use throughout pregnancy in two patients with aquaporin-4-positive neuromyelitis optica spectrum disorder. Clin Clin Exp Neuroimmunol. 2024; 15(3): 126–129. https://doi.org/10.1111/cen3.12784
- 2Sarno L, Tufano A, Maruotti GM, Martinelli P, Balletta MM, Russo D. Eculizumab in pregnancy: a narrative overview. J Nephrol. 2019; 32(1): 17–25. https://doi.org/10.1007/s40620-018-0517-z Epub 2018 Aug 29. PMID: 30159857.
- 3Stefanovic V. The extended use of eculizumab in pregnancy and complement activation−Associated diseases affecting maternal, fetal and neonatal kidneys-the future is now? J Clin Med. 2019; 8(3) 407. https://doi.org/10.3390/jcm8030407 PMID: 30909646; PMCID: PMC6463259.
- 4Siriratnam P, Huda S, Butzkueven H, van der Walt A, Jokubaitis V, Monif M. Risks and outcomes of pregnancy in neuromyelitis optica spectrum disorder: a comprehensive review. Autoimmun Rev. 2024 Feb; 23(2) 103499. https://doi.org/10.1016/j.autrev.2023.103499. Epub 2023 Dec 5 PMID: 38061621.
